Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of October 2023, with a specific reporting date of October 30, 2023. The document serves as a notification of transactions by persons discharging managerial responsibilities (PDMR) in accordance with Article 19 of the UK Market Abuse Regulation.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for the Company. The only financial data provided relates to a specific insider transaction:
- Transaction Type: Purchase of American Depositary Shares (ADSs).
- Price per ADS: USD 25.43.
- Volume: 500 ADSs.
- Total Transaction Value: USD 12,715.00.
Material Changes
There are no material changes to the Company's financial position or operations reported in this filing. The document solely reports a change in shareholding by a Non-Executive Director.
Management Commentary and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It is a statutory disclosure of an insider trade executed on the New York Stock Exchange on October 27, 2023.
Investor Verification Checklist
- Verify the current share price of Rentokil Initial plc ADSs to assess the valuation at the time of the insider purchase.
- Confirm the total number of ADSs held by David Frear post-transaction to understand his total exposure.
- Review the Company's most recent Form 20-F or interim financial report for actual revenue and profit metrics, as they are absent here.